358 related articles for article (PubMed ID: 16936473)
1. Heart rate slowing versus other pharmacological antianginal strategies.
Diaz A; Tardif JC
Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
[TBL] [Abstract][Full Text] [Related]
2. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
Ruzyllo W; Tendera M; Ford I; Fox KM
Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
[TBL] [Abstract][Full Text] [Related]
3. Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine.
Borer JS
Adv Cardiol; 2006; 43():54-64. PubMed ID: 16936472
[TBL] [Abstract][Full Text] [Related]
4. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
Sulfi S; Timmis AD
Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
[TBL] [Abstract][Full Text] [Related]
5. Ivabradine: beyond heart rate control.
Riccioni G; Vitulano N; D'Orazio N
Adv Ther; 2009 Jan; 26(1):12-24. PubMed ID: 19165437
[TBL] [Abstract][Full Text] [Related]
6. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
DiFrancesco D; Camm JA
Drugs; 2004; 64(16):1757-65. PubMed ID: 15301560
[TBL] [Abstract][Full Text] [Related]
7. Selective and specific I(f) inhibition: new perspectives for the treatment of stable angina.
Fox K
Expert Opin Pharmacother; 2006 Jun; 7(9):1211-20. PubMed ID: 16732707
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
Tardif JC; Ford I; Tendera M; Bourassa MG; Fox K;
Eur Heart J; 2005 Dec; 26(23):2529-36. PubMed ID: 16214830
[TBL] [Abstract][Full Text] [Related]
9. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
Borer JS; Fox K; Jaillon P; Lerebours G;
Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
[TBL] [Abstract][Full Text] [Related]
10. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
Tardif JC
Drugs Today (Barc); 2008 Mar; 44(3):171-81. PubMed ID: 18536779
[TBL] [Abstract][Full Text] [Related]
11. Ivabradine in chronic stable angina: Effects by and beyond heart rate reduction.
Camici PG; Gloekler S; Levy BI; Skalidis E; Tagliamonte E; Vardas P; Heusch G
Int J Cardiol; 2016 Jul; 215():1-6. PubMed ID: 27104917
[TBL] [Abstract][Full Text] [Related]
12. Novel If current inhibitor ivabradine: safety considerations.
Savelieva I; Camm AJ
Adv Cardiol; 2006; 43():79-96. PubMed ID: 16936474
[TBL] [Abstract][Full Text] [Related]
13. Ivabradine: new drug. Best avoided in stable angina.
Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
Tardif JC; Ponikowski P; Kahan T;
Eur Heart J; 2009 Mar; 30(5):540-8. PubMed ID: 19136486
[TBL] [Abstract][Full Text] [Related]
15. Focus on ivabradine: a new heart rate-controlling drug.
Riccioni G
Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):107-13. PubMed ID: 19210206
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
Nedoshivin A; Petrova PTS; Karpov Y
Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
[TBL] [Abstract][Full Text] [Related]
17. Future directions: what data do we need?
Tendera M
Adv Cardiol; 2006; 43():106-111. PubMed ID: 16936476
[TBL] [Abstract][Full Text] [Related]
18. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects of the Ιf current inhibition by ivabradine during cardiac dysfunction.
Su JB
Curr Pharm Biotechnol; 2014; 14(14):1213-9. PubMed ID: 24831809
[TBL] [Abstract][Full Text] [Related]
20. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
